INS and type 2 diabetes mellitus: A coding non-synonymous polymorphism of SLC30A8 (R325W; rs13266634) has been demonstrated to be protective for type 2 diabetes [32], [42]–[45] and was shown to influence insulin secretion following an intravenous glucose challenge [7].